| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 05/23/2007 | CN1316959C Acanthopanax bark-ginseng-Chinese angelica root-astragalus root dripping pill and its preparing method |
| 05/23/2007 | CN1316927C Applicaiton of birch fuzz extract for relieving with drawal syndrome for druggy recovery period |
| 05/23/2007 | CN1316922C Anti-fatigue health food and preparation method thereof |
| 05/23/2007 | CN1316911C Health-care tea of prepared rehmannia root |
| 05/22/2007 | US7220880 For therapy of diabetes mellitus, cardiovascular disease, obesity, Syndrome X and gastrointestinal disease, such as, inflammatory bowel disease |
| 05/22/2007 | US7220867 Dissolving with crystal growth inihibitos; drying |
| 05/22/2007 | US7220866 Useful in the treatment of diseases or conditions susceptible to adrenergic regulation controlled by alpha-2 adrenergic receptors |
| 05/22/2007 | US7220860 Anticancer agents |
| 05/22/2007 | US7220780 Naaladase inhibitors for treating retinal disorders and glaucoma |
| 05/22/2007 | US7220779 Using 5-aminolevulinic acid |
| 05/22/2007 | US7220769 Azolylbenzamides and analogues and their use for treating osteoporosis |
| 05/22/2007 | US7220759 Isoquinoline compound and pharmaceutical use thereof |
| 05/22/2007 | US7220758 Immunology for viral diseases and biosynthesis of cytokines of anticancer drugs for tumors |
| 05/22/2007 | US7220754 Mono-ester and asymmetrically substatuted di-ester pro-drugs of dopamide D1 receptor agonists |
| 05/22/2007 | US7220753 2,7-substituted octahydro-1H-pyrido[1,2-a]pyrazine derivatives as ligands for serotonin receptors |
| 05/22/2007 | US7220752 Liver selective glucocorticoid receptor antagonists; lowering blood glucose levels; 3,5-dibromo-4-(5-isopropyl-2-(3-methylbenzoyl)-4-(3-methyl-3-b utenyloxy)phenoxy)-phenylacetic acid for example |
| 05/22/2007 | US7220569 Nucleic acids encoding factor X analogues having a modified protease cleavage site |
| 05/22/2007 | US7220561 Using transgenic bacillus to ferment vitamin b5, valine and isoleucine |
| 05/22/2007 | US7220434 Dual-release compositions of a cyclooxygenase-2 inhibitor |
| 05/22/2007 | CA2382573C Substituted benzylthiazolidine-2,4-dione derivatives |
| 05/22/2007 | CA2368347C Glucokinase activators |
| 05/22/2007 | CA2361844C Carnitine supplemented diet to prevent sudden death syndrome in broiler breeder type poultry |
| 05/22/2007 | CA2325033C Use of ribose to treat fibromyalgia |
| 05/22/2007 | CA2286870C Indazole amide compounds as serotoninergic agents |
| 05/22/2007 | CA2266050C Piperazine derivatives |
| 05/22/2007 | CA2241466C Pharmaceutical composition containing angiotensin ii antagonist |
| 05/22/2007 | CA2212200C Novel inhibitors of .beta.-glucuronidase |
| 05/22/2007 | CA2174327C Combination of progesterone antagonists and anti-oestrogens with partial agonistic action for use in hormone-replacement therapy for peri- and post-menopausal women |
| 05/22/2007 | CA2157146C Heterocyclyl-benzoylguanidines |
| 05/22/2007 | CA2073045C A human t cell reactive feline protein (trfp) isolated from house dust and uses therefor |
| 05/22/2007 | CA2046802C Compositions containing protease produced by vibrio and method of use in debridement and wound healing |
| 05/18/2007 | WO2007055378A1 Method for treatment or prevention of disease associated with functional disorder of regulatory t cell |
| 05/18/2007 | WO2007055224A1 Therapeutic agent for corneal disease |
| 05/18/2007 | WO2007055093A1 Tricyclic compound |
| 05/18/2007 | WO2007054778A1 Pyrazolo[4,3-d]pyrimidin-5-yl)derivative used as pde5 inhibitors |
| 05/18/2007 | WO2007015157A3 Mc4r-ag0nists for the treatment of urinary tract dysfunction |
| 05/18/2007 | WO2007013944A3 Use of truncated cysteine il28 and il29 mutants to treat cancers and autoimmune disorders |
| 05/18/2007 | WO2007011647A3 Inhibitors of mitotic kinesin ksp |
| 05/18/2007 | WO2007008072A3 CROSS-ß STRUCTURE BINDING COMPOUNDS |
| 05/18/2007 | WO2007006544A3 Cyclic adenosine monophosphate compounds for the treatment of immune-related disorders |
| 05/18/2007 | WO2007000036A3 Use of mas g-protein-coupled receptor agonists and antagonists as apoptotic activity modulators for prevention and treatment of diseases |
| 05/18/2007 | WO2000040740A3 Gene therapy to promote angiogenesis |
| 05/17/2007 | US20070112205 Cyanopyrrolidine derivatives |
| 05/17/2007 | US20070112175 Determining drug resistance |
| 05/17/2007 | US20070112061 Heat- or singlet oxygen-generating agents and cancer treatment compositions comprising organic peroxide or chemiluminescent compound |
| 05/17/2007 | US20070112059 Cyanopyrrolidine derivatives |
| 05/17/2007 | US20070112046 2'-Methyl-5'-(1,3,4-Oxadiazol-2-yl)-1,1'-Biphenyl-4-Carboxamide Derivatives and Their Use As P38 Kinase Inhibitors |
| 05/17/2007 | US20070112044 Antitumor, anticancer agents; using a 2-amino-5-phenyl-(1,3,4)thiadiazole compound |
| 05/17/2007 | US20070112040 Amino nicotinate derivatives as glucokinase (GLK) modulators |
| 05/17/2007 | US20070112029 Piperidine compound and process for preparing the same |
| 05/17/2007 | US20070112013 Method of modulating ion channel functional activity |
| 05/17/2007 | US20070112002 1-[2-(4,4-dimethylcyclohexyl)-5-methoxyphenyl]-4-pentylpiperazine; excellent cell adhesion inhibitory action or cell infiltration inhibitory action; inflammatory diseases and autoimmune diseases such as ulcerative colitis, Crohn's disease, irritable bowel syndrome, rheumatoid arthritis, psoriasis, asthma |
| 05/17/2007 | US20070111951 Novel galactosylceramide analogues, and beta-glucocerebrosidase activator, external skin preparations and method of activating beta-glucocerebrosidase using the same |
| 05/17/2007 | US20070111945 Use of corticotroph-derived glycoprotein hormone to treat inflammation and potentiate glucocorticoid action |
| 05/17/2007 | US20070111942 For detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells |
| 05/17/2007 | US20070111266 Antibodies to murine zcytor17 ligand |
| 05/17/2007 | US20070110766 Proteinase K resistant surface protein of neisseria meningitidis |
| 05/17/2007 | US20070110745 Antagonists of TWEAK and of TWEAK receptor and their use to treat immunological disorders |
| 05/17/2007 | US20070110730 Multipotent stem cells from peripheral tissues and uses thereof |
| 05/17/2007 | US20070110708 Silicon compounds and their use |
| 05/16/2007 | EP1785433A1 Viral particle-like construct and method of forming the same under physiological conditions |
| 05/16/2007 | EP1785422A1 Micronised crystalline tiotropium bromide |
| 05/16/2007 | EP1785421A1 Tropan compound |
| 05/16/2007 | EP1785144A2 Combinations of bile acids sequestrant(s) and sterol absorption inhibitor(s) and treatments for vascular indications |
| 05/16/2007 | EP1785139A1 Antagonist against tolerance to anticancer drugs |
| 05/16/2007 | EP1785132A1 Constitutional function-improving agents |
| 05/16/2007 | EP1784181A1 Vegf inhibition |
| 05/16/2007 | EP1465923B1 Corticotropin releasing factor receptor 2 agonists |
| 05/16/2007 | EP1458883B1 Screening method for agents useful in treating diabetes |
| 05/16/2007 | EP1455605B1 Soft drink replacer |
| 05/16/2007 | EP1448544B1 Substituted benzopyrans as selective estrogen receptor-beta agonists |
| 05/16/2007 | EP1390406B1 Method of modulating the proliferation of medullary thyroid carcinoma cells |
| 05/16/2007 | EP1355928B1 Universal carrier for targeting molecules to gb3 receptor expressing cells |
| 05/16/2007 | EP1303307B1 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and alkylating agents |
| 05/16/2007 | EP1262181B1 Use of isothiazole derivatives as urease inhibitors for the treatment of helicobacter pylori induced gastrointestinal diseases |
| 05/16/2007 | EP1129190B1 Human tslp dna and polypeptides |
| 05/16/2007 | EP1127150B1 Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same |
| 05/16/2007 | EP1115405B1 Use of tnf-alpha inhibitors for treating nerve root injury |
| 05/16/2007 | EP1085896B1 Conformationally constrained backbone cyclized somatostatin analogs |
| 05/16/2007 | EP0989853B1 Self-regulated apoptosis of inflammatory cells by gene therapy |
| 05/16/2007 | EP0789567B1 A method for treating vascular headaches |
| 05/16/2007 | CN1964950A Propane-1,3-dione derivative or its salt |
| 05/16/2007 | CN1964733A Novel use of peptide compounds for treating essential tremor and other tremor syndromes |
| 05/16/2007 | CN1962641A Metalloproteinase inhibitors |
| 05/16/2007 | CN1962596A Ketone compounds and compositions for cholesterol management and related uses |
| 05/16/2007 | CN1961937A Ointment for moving blood, resolving stasis, reducing swelling and easing pain and preparation process thereof |
| 05/16/2007 | CN1961891A Radiation resistant composition |
| 05/16/2007 | CN1961749A Application of fructus cannabis in preparation of health food for improving anoxia tolerance |
| 05/16/2007 | CN1315867C 17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivative as anti-inflammatory agents |
| 05/16/2007 | CN1315862C Methods and compositions for treating flaviviruses and pestiviruses |
| 05/16/2007 | CN1315847C 1-thia-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 05/16/2007 | CN1315838C 1-oxa-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 05/16/2007 | CN1315835C Polycyclic guanine phosphodiesterase v inhibitors |
| 05/16/2007 | CN1315833C Azaindole kinase inhibitors |
| 05/16/2007 | CN1315832C Heteroaryl substituted 2-pyridinyl and 2-pyrimidinyl-6,7,8,9-tetrahydropydimido[1,2-a]pyrimidin-4-one derivatives |
| 05/16/2007 | CN1315822C Quinoline derivatives having VEGF inhibiting activity |
| 05/16/2007 | CN1315813C 2-amino-4h-3,1-benzoxazin-4-one derivatives for the treatment of obesity |
| 05/16/2007 | CN1315809C Quinoline derivatives and their use as 5-HT6 ligands |
| 05/16/2007 | CN1315806C Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors |
| 05/16/2007 | CN1315803C Aminopyridyl-substituted phenyl acetamides as protease inhibitors |